Activation of peripheral blood monocytes results in more robust production of IL-10 in neonatal foals compared to adult horses

Veterinary Immunology and Immunopathology

Volumn 127, Issue 1-2, 2009, Pages 167-173

  Sponseller, B A ^a   de Macedo, M M A ^a   Clark, S K ^a   Gallup, J M ^a   Jones, D E ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Cytokine; Equine; Neonate; Real time PCR

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; HORSE; IMMUNE RESPONSE; INNATE IMMUNITY; MONOCYTE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; HORSES; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; RHODOCOCCUS EQUI; RNA, MESSENGER;

EQUIDAE; RHODOCOCCUS EQUI;

EID: 57749206814     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.09.013     Document Type: Article

References (42)

1. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L., and Mantovani A. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28 (1998) 359-369
2. Bean A.G., Freiberg R.A., Andrade S., Menon S., and Zlotnik A. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61 (1993) 4937-4939
3. Buchwald U.K., Geerdes-Fenge H.F., Vockler J., Ziege S., and Lode H. Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone. Eur. J. Med. Res. 4 (1999) 85-94
4. Cenci E., Romani L., Mencacci A., Spaccapelo R., Schiaffella E., Puccetti P., and Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23 (1993) 1034-1038
5. Cunha F.Q., Moncada S., and Liew F.Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem. Biophys. Res. Commun. 182 (1992) 1155-1159
6. Cusumano V., Genovese F., Mancuso G., Carbone M., Fera M.T., and Teti G. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect. Immun. 64 (1996) 2850-2852
7. Denis M., and Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 151 (1993) 5425-5430
8. Florquin S., Amraoui Z., Abramowicz D., and Goldman M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153 (1994) 2618-2623
9. Gallup J.M., and Ackermann M.R. Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions. Biol. Proced. Online 8 (2006) 87-152
10. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kuhn R., Muller W., Trinchieri G., and Sher A. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157 (1996) 798-805
11. Giguere S., Wilkie B.N., and Prescott J.F. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 67 (1999) 5041-5047
12. Ginzinger D.G. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol. 30 (2002) 503-512
13. Goriely S., Van Lint C., Dadkhah R., Libin M., De Wit D., Demonte D., Willems F., and Goldman M. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J. Exp. Med. 199 (2004) 1011-1016
14. Greenberger M.J., Strieter R.M., Kunkel S.L., Danforth J.M., Goodman R.E., and Standiford T.J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155 (1995) 722-729
15. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., DeLuca D., Shenker L., Bard J., and Boyse E.A. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10006-10010
16. Holscher C., Mohrs M., Dai W.J., Kohler G., Ryffel B., Schaub G.A., Mossmann H., and Brombacher F. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 68 (2000) 4075-4083
17. Horowitz M.L., Cohen N.D., Takai S., Becu T., Chaffin M.K., Chu K.K., Magdesian K.G., and Martens R.J. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Intern. Med. 15 (2001) 171-175
18. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., and Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158 (1997) 3311-3316
19. Joss A., Akdis M., Faith A., Blaser K., and Akdis C.A. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 30 (2000) 1683-1690
20. Kato T., Murata A., Ishida H., Toda H., Tanaka N., Hayashida H., Monden M., and Matsuura N. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob. Agents Chemother. 39 (1995) 1336-1340
21. Kawashima K., Meyerholz D.K., Gallup J.M., Grubor B., Lazic T., Lehmkuhl H.D., and Ackermann M.R. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol. 19 (2006) 316-323
22. Kuga S., Otsuka T., Niiro H., Nunoi H., Nemoto Y., Nakano T., Ogo T., Umei T., and Niho Y. Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp. Hematol. 24 (1996) 151-157
23. Lee S.M., Suen Y., Chang L., Bruner V., Qian J., Indes J., Knoppel E., van de Ven C., and Cairo M.S. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88 (1996) 945-954
24. Li C., Corraliza I., and Langhorne J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67 (1999) 4435-4442
25. Marodi L. Down-regulation of Th1 responses in human neonates. Clin. Exp. Immunol. 128 (2002) 1-2
26. Neyer L.E., Grunig G., Fort M., Remington J.S., Rennick D., and Hunter C.A. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65 (1997) 1675-1682
27. Niiro H., Otsuka T., Abe M., Satoh H., Ogo T., Nakano T., Furukawa Y., and Niho Y. Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes. Lymphokine Cytokine Res. 11 (1992) 209-214
28. Pusterla N., Magdesian K.G., Mapes S., and Leutenegger C.M. Expression of molecular markers in blood of neonatal foals with sepsis. Am. J. Vet. Res. 67 (2006) 1045-1049
29. Raabe M.R., Issel C.J., and Montelaro R.C. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Meth. 71 (1998) 87-104
30. Rahim S.S., Khan N., Boddupalli C.S., Hasnain S.E., and Mukhopadhyay S. Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. Immunology 114 (2005) 313-321
31. Reddy R.C., Chen G.H., Newstead M.W., Moore T., Zeng X., Tateda K., and Standiford T.J. Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10. Infect. Immun. 69 (2001) 1394-1401
32. Ridge J.P., Fuchs E.J., and Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271 (1996) 1723-1726
33. Smith T.A., Davis E., and Carpenter S. Endotoxin treatment of EIAV-infected horse macrophage cultures decreases production of infectious virus. J. Gen. Virol. 79 (1998) 747-755
34. Standiford T.J., Strieter R.M., Lukacs N.W., and Kunkel S.L. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155 (1995) 2222-2229
35. Trivedi H.N., HayGlass K.T., Gangur V., Allardice J.G., Embree J.E., and Plummer F.A. Analysis of neonatal T cell and antigen presenting cell functions. Hum. Immunol. 57 (1997) 69-79
36. Tumas D.B., Brassfield A.L., Travenor A.S., Hines M.T., Davis W.C., and McGuire T.C. Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocyte marker and to a unique pan-B lymphocyte marker. Immunobiology 192 (1994) 48-64
37. Upham J.W., Lee P.T., Holt B.J., Heaton T., Prescott S.L., Sharp M.J., Sly P.D., and Holt P.G. Development of interleukin-12-producing capacity throughout childhood. Infect. Immun. 70 (2002) 6583-6588
38. van der Poll T., Marchant A., Buurman W.A., Berman L., Keogh C.V., Lazarus D.D., Nguyen L., Goldman M., Moldawer L.L., and Lowry S.F. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155 (1995) 5397-5401
39. van der Poll T., Marchant A., Keogh C.V., Goldman M., and Lowry S.F. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174 (1996) 994-1000
40. Vengust M., Staempfli H., and Prescott J.F. Rhodococcus equi pleuropneumonia in an adult horse. Can. Vet. J. 43 (2002) 706-708
41. Wu J., Cunha F.Q., Liew F.Y., and Weiser W.Y. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J. Immunol. 151 (1993) 4325-4332
42. Zhou L., Nazarian A.A., and Smale S.T. Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol. Cell. Biol. 24 (2004) 2385-2396